Travere Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results

Rhea-AI Summary

Travere Therapeutics (NASDAQ: TVTX) will announce its fourth quarter and full year 2020 financial results on March 1, 2021, after U.S. market close. A conference call will follow at 4:30 p.m. ET to discuss these results and provide a business update. The call can be accessed via dial-in or live webcast, with a replay available for a week post-call. Travere is focused on developing therapies for rare diseases, emphasizing its commitment to patient needs and insights.

Positive

• Scheduled announcement of fourth quarter and full year 2020 financial results may indicate transparency and engagement with investors.

Negative

• None.

SAN DIEGO, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2020 financial results on Monday, March 1, 2021 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.

Conference Call Information

Date:		Monday, March 1, 2021
Time:		4:30 p.m. ET
Dial-in numbers:		+1 (855) 219-9219 (U.S.) or +1 (315) 625-6891 (International)
Confirmation code:		3397951
Live webcast:		Travere.com in the “Events & Presentations” section of the “Investors” page

A replay of the call will be available from 7:30 p.m. ET, March 1, 2021 to 7:30 p.m. ET, March 8, 2021. The replay number is +1 (855) 859-2056 (U.S.) or +1 (404) 537-3406 (International), confirmation code 3397951.

About Travere Therapeutics

At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.

Contact:
Chris Cline, CFA                                 
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879                                        
IR@travere.com

FAQ

When will Travere Therapeutics report its fourth quarter 2020 financial results?

Travere Therapeutics will report its fourth quarter 2020 financial results on March 1, 2021, after the market close.

What time will the conference call for Travere Therapeutics take place?

The conference call will take place at 4:30 p.m. ET on March 1, 2021.

How can I access the webcast for Travere Therapeutics' financial results?

The webcast can be accessed on Travere's Investor Relations page under the 'Events & Presentations' section.

Is there a replay available for the conference call?

Yes, a replay of the call will be available from March 1, 2021, at 7:30 p.m. ET to March 8, 2021, at 7:30 p.m. ET.